First Manhattan’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

First Manhattan’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-54	Closed	-$5K	–	1740
2021 Q2	$5K	Buy	+54	New	+$4.97K	﹤0.01%	1414
2016 Q4	–	Sell	-16,297	Closed	-$295K	–	1483
2016 Q3	$295K	Hold	16,297	–	–	﹤0.01%	602
2016 Q2	$268K	Sell	16,297 -3,911	-19%	-$63.3K	﹤0.01%	629
2016 Q1	$334K	Hold	20,208	–	–	﹤0.01%	566
2015 Q4	$437K	Hold	20,208	–	–	﹤0.01%	530
2015 Q3	$400K	Buy	+20,208	New	+$638K	﹤0.01%	543

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Manhattan's HZNP Position: Q3 2021 in Review

First Manhattan sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2021, closing a stake of 54 shares — an estimated $5K sold.

First Manhattan first reported a position in HZNP in Q3 2015 and held it in 6 quarters. The position peaked at $437K in Q4 2015. 572 funds tracked by Wall St. Rank hold HZNP as of Q3 2021.

First Manhattan reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2021 after selling out during the quarter.
First Manhattan sold 54 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2021, an estimated $5K.
First Manhattan first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2015 and held it in 6 quarters.
First Manhattan's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $437K in Q4 2015.
572 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2021.

Based on First Manhattan's 13F filing for Q3 2021, filed 15 Nov 2021.